JOAQUÍN ARRIBAS

Oncology
Vall d'Hebron Institut d’Oncologia
Spain

Scientist Oncology
Biography

"Dr. Joaquin Arribas is currently working as a Director of Preclinical Research, Head of the Growth Factors Laboratory, ICREA Research Professor, 2007Director of Preclinical Research, Head of the Growth Factors Laboratory, ICREA Research Professor, 2007.Member of the Executive Committee of the Territorial Network for Cooperative Cancer Research (RTICC), Chairman of the Committee for the Evaluation of Research Projects on Cancer (Cancer Research Fund) of the Carlos III Health Institute, Member of the Spanish and American Society of Biochemistry and Molecular Biology (SEBBM), Member of the Editorial Board of the Journal of Biological Chemistry in the Department of Oncology, Vall d'Hebron Institute of Oncology , Spain. His research interests includes cellular plasticity, stemness and cancer, tumorigenesis, anticancer therapy. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Joaquin Arribas is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to cellular plasticity, stemness and cancer, tumorigenesis, anticancer therapy. "

Research Intrest

Study of the role of certain signal transduction pathways in the development of cancer. Role of the EGF receptor.

List of Publications
Hergueta-Redondo M, Sarrio D, Molina-Crespo Á, Vicario R, Bernadó-Morales C, Martínez L, Rojo-Sebastián A, Serra-Musach J, Mota A, Martínez-Ramírez Á, Castilla MÁ, González-Martin A, Pernas S, Cano A, Cortes J, Nuciforo PG, Peg V, Palacios J, Pujana MÁ, Arribas J, Moreno-Bueno G. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer. Oncotarget. 2016 Aug 30;7(35):56295-56308.
Serra-Musach J, Mateo F, Capdevila-Busquets E, de Garibay GR, Zhang X, Guha R, Thomas CJ, Grueso J, Villanueva A, Jaeger S, Heyn H, Vizoso M, Pérez H, Cordero A, Gonzalez-Suarez E, Esteller M, Moreno-Bueno G, Tjärnberg A, Lázaro C, Serra V, Arribas J, Benson M, Gustafsson M, Ferrer M, Aloy P, Pujana MÀ. Cancer network activity associated with therapeutic response and synergism. Genome Med. 2016 Aug 24;8(1):88.
Morancho B, Zacarías-Fluck M, Esgueva A, Bernadó-Morales C, Di Cosimo S, Prat A, Cortés J, Arribas J, Rubio IT. Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts. Oncotarget. 2016 Oct 18;7(42):67956-67965.